Discussion

Jenny Ting, Timothy W. Behrens, Edward K. Wakeland, Abul K. Abbas, Christopher C. Goodnow, David A. Hafler, Vijay K. Kuchroo, John D. Rioux, Linda S. Wicker, Jane Worthington, Timothy J. Vyse, David B. Goldstein, Simon J. Foote, Juha Kere

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Original languageEnglish (US)
Title of host publicationNovartis Foundation Symposium
Pages160-164
Number of pages5
Volume267
StatePublished - 2005

Publication series

NameNovartis Foundation Symposium
Volume267
ISSN (Print)15282511

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ting, J., Behrens, T. W., Wakeland, E. K., Abbas, A. K., Goodnow, C. C., Hafler, D. A., ... Kere, J. (2005). Discussion. In Novartis Foundation Symposium (Vol. 267, pp. 160-164). (Novartis Foundation Symposium; Vol. 267).

Discussion. / Ting, Jenny; Behrens, Timothy W.; Wakeland, Edward K.; Abbas, Abul K.; Goodnow, Christopher C.; Hafler, David A.; Kuchroo, Vijay K.; Rioux, John D.; Wicker, Linda S.; Worthington, Jane; Vyse, Timothy J.; Goldstein, David B.; Foote, Simon J.; Kere, Juha.

Novartis Foundation Symposium. Vol. 267 2005. p. 160-164 (Novartis Foundation Symposium; Vol. 267).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Ting, J, Behrens, TW, Wakeland, EK, Abbas, AK, Goodnow, CC, Hafler, DA, Kuchroo, VK, Rioux, JD, Wicker, LS, Worthington, J, Vyse, TJ, Goldstein, DB, Foote, SJ & Kere, J 2005, Discussion. in Novartis Foundation Symposium. vol. 267, Novartis Foundation Symposium, vol. 267, pp. 160-164.
Ting J, Behrens TW, Wakeland EK, Abbas AK, Goodnow CC, Hafler DA et al. Discussion. In Novartis Foundation Symposium. Vol. 267. 2005. p. 160-164. (Novartis Foundation Symposium).
Ting, Jenny ; Behrens, Timothy W. ; Wakeland, Edward K. ; Abbas, Abul K. ; Goodnow, Christopher C. ; Hafler, David A. ; Kuchroo, Vijay K. ; Rioux, John D. ; Wicker, Linda S. ; Worthington, Jane ; Vyse, Timothy J. ; Goldstein, David B. ; Foote, Simon J. ; Kere, Juha. / Discussion. Novartis Foundation Symposium. Vol. 267 2005. pp. 160-164 (Novartis Foundation Symposium).
@inproceedings{c5aa2f08fa56493ca3d825416fc158aa,
title = "Discussion",
author = "Jenny Ting and Behrens, {Timothy W.} and Wakeland, {Edward K.} and Abbas, {Abul K.} and Goodnow, {Christopher C.} and Hafler, {David A.} and Kuchroo, {Vijay K.} and Rioux, {John D.} and Wicker, {Linda S.} and Jane Worthington and Vyse, {Timothy J.} and Goldstein, {David B.} and Foote, {Simon J.} and Juha Kere",
year = "2005",
language = "English (US)",
isbn = "9780470021378",
volume = "267",
series = "Novartis Foundation Symposium",
pages = "160--164",
booktitle = "Novartis Foundation Symposium",

}

TY - GEN

T1 - Discussion

AU - Ting, Jenny

AU - Behrens, Timothy W.

AU - Wakeland, Edward K.

AU - Abbas, Abul K.

AU - Goodnow, Christopher C.

AU - Hafler, David A.

AU - Kuchroo, Vijay K.

AU - Rioux, John D.

AU - Wicker, Linda S.

AU - Worthington, Jane

AU - Vyse, Timothy J.

AU - Goldstein, David B.

AU - Foote, Simon J.

AU - Kere, Juha

PY - 2005

Y1 - 2005

UR - http://www.scopus.com/inward/record.url?scp=55949121024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55949121024&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:55949121024

SN - 9780470021378

VL - 267

T3 - Novartis Foundation Symposium

SP - 160

EP - 164

BT - Novartis Foundation Symposium

ER -